Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging

Journal of Ophthalmic Inflammation and Infection

Table 1 Demographic data and clinical features of patients with acute central serous chorioretinopathy included in the study

Patient no.	Sex	Age (years)	Eye	BCVA	Anterior segment features	Posterior segment features	Systemic features and steroid exposure	Total follow-up (weeks)
1	M	32	OD	0.8	–	SSRD and PED	Nil	6
1	M	32	OS	0.2	–	–	Nil	6
2	M	41	OD	0	–	–	Nil	12
2	M	41	OS	0.2	–	SSRD	Nil	12
3	M	33	OD	0.2	–	–	Local steroid use for dermatological condition	8
3	M	33	OS	0.8	–	SSRD	Local steroid use for dermatological condition	8
4	F	38	OD	0	–	–	Oral herbal medications for hypertension	2
4	F	38	OS	0.2	–	SSRD and PED	Oral herbal medications for hypertension	2
5	M	37	OD	0.8	–	SSRD	Oral herbal medications for renal calculi	8
5	M	37	OS	0	–	–	Oral herbal medications for renal calculi	8
6	M	32	OD	0.2	–	–	Local steroid use for tinea	4
6	M	32	OS	0.48	–	SSRD	Local steroid use for tinea	4
7	M	35	OD	0	–	SSRD and PED	Oral steroids for asthma	6
7	M	35	OS	0	–	–	Oral steroids for asthma	6
8	M	32	OD	0	–	PED	Nil	12
8	M	32	OS	0.48	–	SSRD and PED	Nil	12
9	M	27	OD	0	–	–	Nil	14
9	M	27	OS	0.3	–	SSRD and PED	Nil	14
10	M	32	OD	0.2	–	SSRD	Nil	9
10	M	32	OS	0	–	–	Nil	9
11	F	24	OD	0.1	–	SSRD and PED	Local steroid use for dermatological condition	5
11	F	24	OS	0.1	–	–	Local steroid use for dermatological condition	5
12	M	44	OD	0.3	–	SSRD	Oral steroids for joint pains	10
12	M	44	OS	0	–	–	Oral steroids for joint pains	10
13	M	38	OD	0	–	–	Nil	12
13	M	38	OS	0.1	–	SSRD and PED	Nil	12
14	M	39	OD	0.2	–	SSRD and PED	Oral herbal medications for fatigue	4
14	M	39	OS	0	–	–	Oral herbal medications for fatigue	4

BCVA best-corrected visual acuity, F female, M male, OD right eye, OS left eye, PED pigment epithelial detachment, SSRD subfoveal serous retinal detachment